Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclizumab for Active Anterior Uveitis in JIA
NCT00130637Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Aug 2005
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of daclizumab in anterior uveitis (AU), sponsored by National Eye Institute. Started Aug 2005; status: completed.
02
Drugs
daclizumab
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT00130637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130637.